From: SFRP-4 abrogates Wnt-3a-induced β-catenin and Akt/PKB signalling and reverses a Wnt-3a-imposed inhibition of in vitro mammary differentiation
Cell Type
Treatment
Transmonolayer resistance* (Ohms × cm2)
31E-pBabeVector
w/o Wnt-3a
290 +/- 22
+ Wnt-3a
620 +/- 36
31E-pBabeSFRP-4
250 +/- 18
310 +/- 27